Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Andrews

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
American Biotechnology Laboratory|June 1, 1996
Experimental strategies enabled by C-terminal protein sequence analysisC G Miller, J M Bailey, K Swiderek, et al.
Analytical Chemistry|September 25, 2001
Virtual 2-D gel electrophoresis: visualization and analysis of the E. coli proteome by mass spectrometryR R Loo, J D Cavalcoli, R A VanBogelen, et al.
Journal of Vascular Surgery|May 1, 1995
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamineT W Wakefield, P C Andrews, S K Wrobleski, et al.
The Journal of Surgical Research|June 1, 1996
A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulationT W Wakefield, P C Andrews, S K Wrobleski, et al.
General and Comparative Endocrinology|August 1, 1986
Characterization of coho salmon (Oncorhynchus kisutch) islet somatostatinsE M Plisetskaya, H G Pollock, J B Rouse, et al.
The Journal of Biological Chemistry|March 25, 1994
GP-3, a newly characterized glycoprotein on the inner surface of the zymogen granule membrane, undergoes regulated secretionA C Wagner, M J Wishart, S M Mulders, et al.
Laboratory Animal Science|April 1, 1997
Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine modelM S Hulin, T W Wakefield, P C Andrews, et al.
The Journal of Surgical Research|June 1, 1994
Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analoguesT W Wakefield, P C Andrews, S K Wrobleski, et al.
The Journal of Biological Chemistry|July 5, 1993
Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometryY K Wang, P C Liao, J Allison, et al.
Circulation|November 1, 1995
Direct effects of protamine sulfate on myocyte contractile processes. Cellular and molecular mechanismsR B Hird, T W Wakefield, R Mukherjee, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
American Biotechnology Laboratory|June 1, 1996
Experimental strategies enabled by C-terminal protein sequence analysisC G Miller, J M Bailey, K Swiderek, et al.
Analytical Chemistry|September 25, 2001
Virtual 2-D gel electrophoresis: visualization and analysis of the E. coli proteome by mass spectrometryR R Loo, J D Cavalcoli, R A VanBogelen, et al.
Journal of Vascular Surgery|May 1, 1995
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamineT W Wakefield, P C Andrews, S K Wrobleski, et al.
The Journal of Surgical Research|June 1, 1996
A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulationT W Wakefield, P C Andrews, S K Wrobleski, et al.
General and Comparative Endocrinology|August 1, 1986
Characterization of coho salmon (Oncorhynchus kisutch) islet somatostatinsE M Plisetskaya, H G Pollock, J B Rouse, et al.
The Journal of Biological Chemistry|March 25, 1994
GP-3, a newly characterized glycoprotein on the inner surface of the zymogen granule membrane, undergoes regulated secretionA C Wagner, M J Wishart, S M Mulders, et al.
Laboratory Animal Science|April 1, 1997
Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine modelM S Hulin, T W Wakefield, P C Andrews, et al.
The Journal of Surgical Research|June 1, 1994
Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analoguesT W Wakefield, P C Andrews, S K Wrobleski, et al.
The Journal of Biological Chemistry|July 5, 1993
Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometryY K Wang, P C Liao, J Allison, et al.
Circulation|November 1, 1995
Direct effects of protamine sulfate on myocyte contractile processes. Cellular and molecular mechanismsR B Hird, T W Wakefield, R Mukherjee, et al.
Pageof 11